Abstract
Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have